120017
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.6 Breast Cancer (Dove Med Press)
- 4.3 Clin Epidemiol
- 2.6 Cancer Manag Res
- 3.2 Infect Drug Resist
- 4.1 Clin Interv Aging
- 6.1 Drug Des Dev Ther
- 4.1 Int J Chronic Obstr
- 8.7 Int J Nanomed
- 2.5 Int J Women's Health
- 3.2 Neuropsych Dis Treat
- 2.4 OncoTargets Ther
- 2.6 Patient Prefer Adher
- 2.6 Ther Clin Risk Manag
- 3.1 J Pain Res
- 3.5 Diabet Metab Synd Ob
- 4.5 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 2.4 Pharmgenomics Pers Med
- 2.6 Risk Manag Healthc Policy
- 4.6 J Inflamm Res
- 2.3 Int J Gen Med
- 3.9 J Hepatocell Carcinoma
- 3.3 J Asthma Allergy
- 2.5 Clin Cosmet Investig Dermatol
- 3.0 J Multidiscip Healthc
已发表论文
三才配穴法针刺治疗原发性失眠：一项随机对照试验
Authors Zhao N, Wang Q, Li L, Tang L, Yu X , Liang R, Cun H, Li J, Yang W , Chen Y
Received 4 January 2026
Accepted for publication 19 March 2026
Published 21 April 2026 Volume 2026:18 590127
DOI https://doi.org/10.2147/NSS.S590127
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Ahmed BaHammam
Na Zhao,1,* Qianqian Wang,1,* Lutong Li,1 Lin Tang,2 Xintong Yu,1 Ruilong Liang,1 Haifeng Cun,1 Jinjin Li,1 Wenjia Yang,1 Yunfei Chen1
1Department of Acupuncture and Moxibustion, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, People’s Republic of China; 2Department of Rehabilitation, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Wenjia Yang, Department of Acupuncture and Moxibustion, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, No. 110 Ganhe Road, Hongkou District, Shanghai, 200437, People’s Republic of China, Tel/Fax +86-21-65161687, Email yangwenjia1030@163.com Yunfei Chen, Department of Acupuncture and Moxibustion, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, No. 110 Ganhe Road, Hongkou District, Shanghai, 200437, People’s Republic of China, Tel/Fax +86-21-65162628, Email icyf1968@163.com
Study Objectives: Primary insomnia (PI) remains a widespread public health concern. This study aims to evaluate the efficacy and safety of the novel Sancai acupoint matching method for PI, and to explore its potential peripheral biochemical mechanisms.
Methods and Design: 76 PI patients were randomly assigned to either the real-acupuncture (RA) group or the sham-acupuncture (SA) group, with 38 cases in each group. The RA group received verum acupuncture based on the stated principle over an 8-week treatment period (20 sessions), while the SA group received sham acupuncture. Assessments were conducted at baseline, immediately post-treatment, and at 1, 4- and 12-week follow-ups using the Insomnia Severity Index (ISI) as the primary outcome measure, along with the Pittsburgh Sleep Quality Index (PSQI), Self-Rating Anxiety Scale (SAS), Self-Rating Depression Scale (SDS). Objective sleep parameters were monitored via polysomnography (PSG), and serum levels of 5-hydroxytryptamine (5-HT) and brain-derived neurotrophic factor (BDNF) were measured before and after treatment.
Results: Improvements in ISI, PSQI, SAS and SDS scores were superior in the RA group compared to the SA group (P < 0.05). The objective sleep parameters in the RA group were significantly improved, and the levels of serum 5-HT and BDNF were significantly increased (P < 0.05).
Conclusion: The Sancai acupoint matching method is a safe and effective treatment for primary insomnia, significantly improving patients’ subjective sleep quality, emotional symptoms, and objective sleep parameters, and upregulating peripheral blood levels of 5-HT and BDNF. These findings support the clinical application of this acupuncture protocol and provide a foundation for subsequent mechanistic studies.
Clinical Trial Registration: The study was registered at the Chinese Clinical Trial.
Registry, registration ID: ChiCTR2300072229, China.
Keywords: acupuncture, Sancai acupoint matching method, primary insomnia, randomized controlled trial, 5-HT, BDNF
1Department of Acupuncture and Moxibustion, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, People’s Republic of China; 2Department of Rehabilitation, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Wenjia Yang, Department of Acupuncture and Moxibustion, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, No. 110 Ganhe Road, Hongkou District, Shanghai, 200437, People’s Republic of China, Tel/Fax +86-21-65161687, Email yangwenjia1030@163.com Yunfei Chen, Department of Acupuncture and Moxibustion, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, No. 110 Ganhe Road, Hongkou District, Shanghai, 200437, People’s Republic of China, Tel/Fax +86-21-65162628, Email icyf1968@163.com
Study Objectives: Primary insomnia (PI) remains a widespread public health concern. This study aims to evaluate the efficacy and safety of the novel Sancai acupoint matching method for PI, and to explore its potential peripheral biochemical mechanisms.
Methods and Design: 76 PI patients were randomly assigned to either the real-acupuncture (RA) group or the sham-acupuncture (SA) group, with 38 cases in each group. The RA group received verum acupuncture based on the stated principle over an 8-week treatment period (20 sessions), while the SA group received sham acupuncture. Assessments were conducted at baseline, immediately post-treatment, and at 1, 4- and 12-week follow-ups using the Insomnia Severity Index (ISI) as the primary outcome measure, along with the Pittsburgh Sleep Quality Index (PSQI), Self-Rating Anxiety Scale (SAS), Self-Rating Depression Scale (SDS). Objective sleep parameters were monitored via polysomnography (PSG), and serum levels of 5-hydroxytryptamine (5-HT) and brain-derived neurotrophic factor (BDNF) were measured before and after treatment.
Results: Improvements in ISI, PSQI, SAS and SDS scores were superior in the RA group compared to the SA group (P < 0.05). The objective sleep parameters in the RA group were significantly improved, and the levels of serum 5-HT and BDNF were significantly increased (P < 0.05).
Conclusion: The Sancai acupoint matching method is a safe and effective treatment for primary insomnia, significantly improving patients’ subjective sleep quality, emotional symptoms, and objective sleep parameters, and upregulating peripheral blood levels of 5-HT and BDNF. These findings support the clinical application of this acupuncture protocol and provide a foundation for subsequent mechanistic studies.
Clinical Trial Registration: The study was registered at the Chinese Clinical Trial.
Registry, registration ID: ChiCTR2300072229, China.
Keywords: acupuncture, Sancai acupoint matching method, primary insomnia, randomized controlled trial, 5-HT, BDNF